These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8552761

  • 41. Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test.
    Gutierrez-Galhardo MC, Zancopé-Oliveira RM, Monzón A, Rodriguez-Tudela JL, Cuenca-Estrella M.
    Mycoses; 2010 May; 53(3):227-31. PubMed ID: 19389067
    [Abstract] [Full Text] [Related]

  • 42. Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
    Chang HC, Chang JJ, Huang AH, Chang TC.
    J Clin Microbiol; 2000 Mar; 38(3):971-6. PubMed ID: 10698982
    [Abstract] [Full Text] [Related]

  • 43. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
    Vardar-Unlu G, Yağmuroğlu A, Unlu M.
    Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
    [Abstract] [Full Text] [Related]

  • 44. Effects of the combination of ketoconazole and calmodulin inhibitors against Candida albicans in vitro. Short communication.
    Krajewska-Kułak E, Niczyporuk W.
    Arzneimittelforschung; 1993 Sep; 43(9):1018-9. PubMed ID: 8240451
    [Abstract] [Full Text] [Related]

  • 45. Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
    Han HS, Kano R, Chen C, Noli C.
    Vet Dermatol; 2017 Feb; 28(1):156-e32. PubMed ID: 28133872
    [Abstract] [Full Text] [Related]

  • 46. Susceptibility of Candida species strains to five antifungal agents: comparison between agar dilution and disk diffusion tests.
    Trancassini M, Ghezzi MC, Cipriani P, Mancini C, Brenciaglia MI.
    Chemioterapia; 1986 Feb; 5(1):14-7. PubMed ID: 3955776
    [Abstract] [Full Text] [Related]

  • 47. Comparison between E-test and CLSI broth microdilution method for antifungal susceptibility testing of Candida albicans oral isolates.
    Koga-Ito CY, Lyon JP, Resende MA.
    Rev Inst Med Trop Sao Paulo; 2008 Feb; 50(1):7-10. PubMed ID: 18327480
    [Abstract] [Full Text] [Related]

  • 48. Comparative evaluation of a new fluorescent carboxyfluorescein diacetate-modified microdilution method for antifungal susceptibility testing of Candida albicans isolates.
    Liao RS, Rennie RP, Talbot JA.
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3236-42. PubMed ID: 12234850
    [Abstract] [Full Text] [Related]

  • 49. In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis.
    Vitale RG, Perez-Blanco M, De Hoog GS.
    Med Mycol; 2009 Feb; 47(1):35-40. PubMed ID: 19115138
    [Abstract] [Full Text] [Related]

  • 50. Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes.
    Fernández-Torres B, Carrillo-Muñoz A, Ortoneda M, Pujol I, Pastor FJ, Guarro J.
    Med Mycol; 2003 Apr; 41(2):125-30. PubMed ID: 12964844
    [Abstract] [Full Text] [Related]

  • 51. Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.
    Valentin A, Le Guennec R, Rodriguez E, Reynes J, Mallie M, Bastide JM.
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1342-5. PubMed ID: 8725998
    [Abstract] [Full Text] [Related]

  • 52. Anticandidal activity of flunarizine.
    Krajewska-Kułak E, Niczyporuk WW.
    Mater Med Pol; 1993 Jun; 25(3-4):143-4. PubMed ID: 8072319
    [Abstract] [Full Text] [Related]

  • 53. [Sensitivity of Aspergillus to ketoconazole and itraconazole using a standardized micromethod].
    Guinet R, Marlier H.
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):572-4. PubMed ID: 2166936
    [Abstract] [Full Text] [Related]

  • 54. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.
    Pfaller MA, Messer SA, Coffmann S.
    J Clin Microbiol; 1995 May; 33(5):1094-7. PubMed ID: 7615712
    [Abstract] [Full Text] [Related]

  • 55. Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testing.
    Messer SA, Pfaller MA.
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):77-81. PubMed ID: 8882893
    [Abstract] [Full Text] [Related]

  • 56. Multicenter evaluation of commercial frozen plates for microdilution broth antifungal susceptibility testing of yeasts and comparison of MIC limits recommended in NCCLS M27-A2.
    Makimura K, Oguri T, Mikami Y, Kume H, Hanazawa R, Abe M, Ikeda R, Shinoda T.
    Microbiol Immunol; 2005 Jun; 49(2):97-106. PubMed ID: 15722594
    [Abstract] [Full Text] [Related]

  • 57. [Antimycotic susceptibility testing of yeasts important in dermato-venereology: methods, results and clinical relevance].
    Korting HC, Georgii A.
    Hautarzt; 1988 Jun; 39(6):343-7. PubMed ID: 3042703
    [Abstract] [Full Text] [Related]

  • 58. In vitro antifungal susceptibility testing of Scopulariopsis brevicaulis strains using agar diffusion method.
    Skóra M, Macura AB.
    Wiad Parazytol; 2011 Jun; 57(2):111-6. PubMed ID: 21682097
    [Abstract] [Full Text] [Related]

  • 59. Determination of sensitivity to antifungal drugs: evaluation of an API kit.
    Philpot CM, Charles D.
    Br J Biomed Sci; 1993 Mar; 50(1):27-30. PubMed ID: 8032291
    [Abstract] [Full Text] [Related]

  • 60. [A comparative study between broth dilution and agar dilution technics in antibiograms for Candida].
    Alves SH, Cury AE.
    Rev Inst Med Trop Sao Paulo; 1992 Mar; 34(3):259-62. PubMed ID: 1342081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.